Dr. Kenji Kabashima

Graduate School of Medicine

Kyoto University, Japan

Email: [email protected]

Qualifications

2003 Ph.D., Kyoto University, Faculty of Medicine

1996 M.D., Kyoto University, Faculty of Medicine

Publications (Selected)

1. Nakamizo, S., Doi, H., & Kabashima, K. (2024). Metabolic dynamics in psoriatic epidermis: enhanced glucose and lactate uptake, glycolytic pathway and TCA cycle dynamics. Experimental Dermatology, 33(7), e15127.
2. Takegami, T., Yonekura, S., Nakajima, S., & Kabashima, K. (2024). Successful treatment of dupilumab‐resistant scaly erythroderma in Netherton syndrome with baricitinib: A case report. The Journal of Dermatology, 51(11), e410-e411.
3. Mostafa, A., Sakurai, K., Murata, T., Dainichi, T., Tian, H., Yodoi, J., & Kabashima, K. (2024). Recombinant human thioredoxin ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Journal of Dermatological Science, 116(1), 55-58.
4. Sawada, T., Kuwai, T., Nakajima, S., Chen‐Yoshikawa, T. F., Nomura, T., Date, H., & Kabashima, K. (2024). Urticaria induced by continuous intravenous epoprostenol treatment in a patient with pulmonary arterial hypertension. The Journal of Dermatology, 51(12), e431-e432.
5. Nakajima, S., Nakamizo, S., Nomura, T., Ishida, Y., Sawada, Y., & Kabashima, K. (2024). Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions. Allergy.
6. Teraoka, M., Yonekura, S., Takegami, T., Murata, T., Egawa, G., Nakajima, S., & Kabashima, K. (2024). Effective treatment of topical corticosteroid-resistant dermatitis with delgocitinib in a pediatric patient with Netherton syndrome. The Journal of Dermatology.
7. Kataoka, K., Nakajima, S., Nomura, T., & Kabashima, K. (2024). Acneiform Eruptions Possibly Triggered by Clarithromycin During Sirolimus Treatment. Cureus, 16(5).
8. Saika, A., Nagatake, T., Kishino, S., Kitamura, N., Honda, T., Hosomi, K., ... & Kunisawa, J. (2024). The omega-3 postbiotic trans-10-cis-15-octadecadienoic acid attenuates contact hypersensitivity in mice through downregulation of vascular endothelial growth factor A. Frontiers in Cellular and Infection Microbiology, 14, 1355679.
9. Kojima, M., Mieno, H., Ueta, M., Nakata, M., Teramukai, S., Sunaga, Y., ... & Sotozono, C. (2024). Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A National Survey in Japan. American Journal of Ophthalmology.
10. Sakiyama, T., Nakamizo, S., & Kabashima, K. (2024). Comparative analysis of CAII and GCDFP-15 expression in sweat glands unveiling the pathophysiology of acquired idiopathic generalized anhidrosis. The Journal of Dermatology.
11. Guttman‐Yassky, E., Kabashima, K., Staumont‐Salle, D., Nahm, W. K., Pauser, S., Da Rosa, J. C., ... & Reich, K. (2024). Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. Allergy.
12. Cho, R., Nakajima, S., Kaku, Y., Tezuka, J., Fujimoto, M., Kambe, N., & Kabashima, K. (2024). Proteasome inhibitor‐associated histiocytoid Sweet's syndrome: Clinical and histological similarities to Nakajo‐Nishimura syndrome suggest a potential mechanism. The Journal of Dermatology.
13. Crépy, M. N., Weidinger, S., Beck, L. A., De Bruin-Weller, M. S., Kabashima, K., Guttman-Yassky, E., ... & Bastian, M. (2024). Baseline serum biomarkers do not predict dupilumab treatment response in adults with moderate-to-severe atopic dermatitis. Revue Française d'Allergologie, 64, 104045.
14. Budair, F., Kambe, N., Kogame, T., Hirata, M., Takimoto‐Ito, R., Mostafa, A., ... & Kabashima, K. (2024). Presence of immunoglobulin E‐expressing antibody‐secreting cells in the dermis close to bullous pemphigoid lesions. Experimental Dermatology, 33(4), e15058.
15. Hirano-Lotman, Y., Ishida, Y., Kaku, Y., Ogawa, S., & Kabashima, K. (2024). Exome sequencing reveals biallelic inactivation of KMT2C in cutaneous apocrine carcinoma: A case report and review of the literature. JAAD Case Reports.
16. Croft, M., Esfandiari, E., Chong, C., Hsu, H., Kabashima, K., Kricorian, G., ... & Guttman-Yassky, E. (2024). Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target. American Journal of Clinical Dermatology, 25(3), 463.
17. Silverberg, J. I., Guttman-Yassky, E., Simpson, E. L., Papp, K. A., Blauvelt, A., Chu, C. Y., ... & Irvine, A. D. (2024). Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results.
18. Budair, F. M., Nomura, T., Hirata, M., & Kabashima, K. (2024). PNAd-expressing vessels characterize the dermis of CD3+ T-cell-mediated cutaneous diseases. Clinical and Experimental Immunology, 216(1), 80-88.
19. Guttman-Yassky, E., Simpson, E. L., Reich, K., Kabashima, K., Igawa, K., Suzuki, T., ... & Furue, M. (2024). Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study. Advances in Therapy, 41(3), 928-931.
20. Masuda, T., Yonekura, S., Kataoka, K., Mizoguchi, K., Hirata, M., Fujimoto, M., ... & Kabashima, K. (2023). Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment. The Journal of Dermatology.
21. Nagatsuka, Y., Nakashima, C., Kitayama, N., Ishida, Y., Kabashima, K., & Otsuka, A. (2024). A case of unilateral epidermal nevi complicated by atopic dermatitis treated with dupilumab. Trends in Immunotherapy, 8(1).
22. Takata, M., Usui, S., Kogame, T., Otsuka, A., & Kabashima, K. (2023). Mucous membrane pemphigoid involving palmoplantar lesions that developed during adjuvant nivolumab for malignant melanoma: A rare case and literature review. Trends in Immunotherapy, 7(2), 2779.
23. Nakaizumi, H., Kambe, N., Irie, H., Kaku, Y., Fujimoto, M., Yoshifuji, H., ... & Kabashima, K. (2024). Neutrophilic epitheliotropism, proposed as an auto‐inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases. The Journal of Dermatology, 51(4), 592-596.
24. Nakamizo, S., Sugiura, Y., Ishida, Y., Ueki, Y., Yonekura, S., Tanizaki, H., ... & Kabashima, K. (2023). Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. Journal of Clinical Investigation, 133(23), e171088.
25. Tie, D., Ishida, Y., Nakajima, S., & Kabashima, K. (2024). Molecular Characterization of Aged Human Eccrine Sweat Gland Cells Using Single-Cell Transcriptomic Analysis. The Journal of investigative dermatology, 144(6), 1389-1391.

Profile Details

https://www.researchgate.net/profile/Kenji-Kabashima-2

https://scholar.google.com/citations?user=5uwXXKAAAAAJ&hl=zh-CN